Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 70
- Registration Number
- NCT05555589
- Locations
- 🇺🇸
Advance Vision Research Institute, Longmont, Colorado, United States
🇺🇸Washington University Eye Center, Saint Louis, Missouri, United States
🇺🇸Connecticut Eye Consultants, P.C. Danbury Eye Physicians & Surgeons, Danbury, Connecticut, United States
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 700
- Registration Number
- NCT03937882
- Locations
- 🇺🇸
Oculus Research, Inc. at the Eye Care Center, Raleigh, North Carolina, United States
🇺🇸Center For Sight, Henderson, Nevada, United States
🇺🇸Dovilan Wyatt MD, LLC, Chicago, Illinois, United States
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 601
- Registration Number
- NCT02974907
- Locations
- 🇺🇸
Andover, MA, Andover, Massachusetts, United States
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT02600429
- Locations
- 🇺🇸
Insight Vision Group, Parker, Colorado, United States
🇺🇸The Eye Care Institute, Louisville, Kentucky, United States
🇺🇸Hull Eye Center, Lancaster, California, United States
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2019-10-17
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 317
- Registration Number
- NCT02597803
- Locations
- 🇺🇸
Andover, MA, Andover, Massachusetts, United States
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2015-07-10
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 72
- Registration Number
- NCT01387347
A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- ReGenTree, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT00598871
- Locations
- 🇺🇸
Southeast Retina Center, Augusta, Georgia, United States
🇺🇸Western Carolina Retinal Associates, PA, Asheville, North Carolina, United States
🇺🇸Doheny Eye Institute, Los Angeles, California, United States